196 related articles for article (PubMed ID: 36614071)
1. Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy.
Malinovskaya J; Salami R; Valikhov M; Vadekhina V; Semyonkin A; Semkina A; Abakumov M; Harel Y; Levy E; Levin T; Persky R; Chekhonin V; Lellouche JP; Melnikov P; Gelperina S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614071
[TBL] [Abstract][Full Text] [Related]
2. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
Kefayat A; Vaezifar S
Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
[TBL] [Abstract][Full Text] [Related]
5. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
7. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
8. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
Wohlfart S; Khalansky AS; Gelperina S; Maksimenko O; Bernreuther C; Glatzel M; Kreuter J
PLoS One; 2011 May; 6(5):e19121. PubMed ID: 21573151
[TBL] [Abstract][Full Text] [Related]
9. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
Sheikhzadeh S; Delirezh N; Hobbenaghi R
Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
12. In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles.
Anasamy T; Chee CF; Kiew LV; Chung LY
Eur J Pharm Sci; 2020 Jan; 142():105140. PubMed ID: 31704345
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
Siddharth S; Nayak A; Nayak D; Bindhani BK; Kundu CN
Sci Rep; 2017 May; 7(1):2143. PubMed ID: 28526868
[TBL] [Abstract][Full Text] [Related]
14. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
16. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W
Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
19. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
Samkange T; D'Souza S; Obikeze K; Dube A
J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.
Miller HA; Frieboes HB
Pharm Res; 2019 Nov; 36(12):185. PubMed ID: 31773287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
